Axsome Logo.png
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
09 nov. 2022 07h00 HE | Axsome Therapeutics, Inc.
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Axsome Logo.png
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
07 nov. 2022 07h00 HE | Axsome Therapeutics, Inc.
Sunosi® third quarter U.S. net sales of $16.8 million Auvelity™ launched and available in U.S. pharmacies SHARP study results announced demonstrating statistically significant improvement in...
ACTIVE HEALTH FOODS, INC. ANNOUNCES ADDITIONAL INDUSTRY LEADERS TO ITS BOARD OF DIRECTORS
27 juin 2022 10h00 HE | Active Health Foods, Inc.
Los Angeles, CA, June 27, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Jonathan Wright, of Tahoma, Washington, and his wife, Holly Han, together with Michael...
Color Logo.png
Bio Solvents Market is expected to grow from USD 9.1 Billion in 2020 to USD 15.9 Billion by 2028, at a CAGR of 7.2% during the forecast period 2021-2028 : Greyviews
29 avr. 2022 05h50 HE | GreyViews
Pune India, April 29, 2022 (GLOBE NEWSWIRE) -- Bio solvents market is anticipated to grow at a steady growth rate over the forecast period, owing to increasing awareness regarding environmentally...
VIPC Funding will further Charlottesville's BioHub goals to advance entrepreneurship in the area's biotechnology sector and support tech and other innovation-led sectors with resourcing and connection
VIPC Regional Innovation Fund Grant Awarded to Charlottesville BioHub to Strengthen the Entrepreneurial Ecosystem in the Charlottesville Region
24 févr. 2022 12h29 HE | Virginia Innovation Partnership Corporation (VIPC)
Richmond, Virginia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- CvilleBioHub, an industry-led 501c3 nonprofit organization dedicated to strengthening Charlottesville’s biotechnology industry sector, today...
Longhorn Vaccines & Diagnostics and SiO2 Materials Science Team Up to Develop 12 Millimeter Sample Transport Media for Higher Volumes of Automated Virus Testing
30 sept. 2021 19h39 HE | SiO2 Materials Science
AUBURN, Ala., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in...
QMI-Logo-Long-1000px.jpg
Global Compound Management Market Size to Grow at a CAGR of 13.8% from 2021 to 2030
11 août 2021 07h30 HE | Quince Market Insights
Pune, India, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The compound management market reached USD 350.38 Million in 2021 and it is projected to grow at a CAGR of 13.8% during the forecast period 2021-2030....
Axiom_20Years_Updated logo.jpg
Axiom Presents "Benefits and Advantages of a Unified Platform Approach to Global Studies" at BIO Digital 2021
10 juin 2021 09h10 HE | Axiom Real-Time Metrics Inc
TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
7 Hills Logo.png
7 Hills Pharma Announces First Healthy Volunteers Dosed in Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
09 nov. 2020 05h30 HE | 7 Hills Pharma
HOUSTON, Nov. 09, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
7 Hills Logo.png
7 Hills Pharma Highlights Cell Adhesion as Key to Improving Effectiveness of Covid-19 Vaccines and Immuno-Oncology Drugs At BIO Digital 2020 Online Conference
15 juin 2020 10h39 HE | 7 Hills Pharma
HOUSTON, June 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...